High-purity reproduction of breast milk-derived components using chemical and enzymatic synthesis technology. Mass production and supply of synthetic HMOs with excellent safety and lot stability for the development of infant nutrition and functional products.
HMOs (Human Milk Oligosaccharides) are a group of functional oligosaccharides that are abundant in breast milk, and they are gaining attention for their roles in regulating the immune system, supporting the formation of gut flora, and aiding in neurodevelopment during growth periods. Our HMO series is produced as high-purity raw materials through "synthesis," utilizing advanced synthetic technologies such as chemical synthesis and enzyme synthesis to achieve stable quality, high purity, and minimal variability between batches.
Through synthetic methods, we can produce each structure derived from breast milk composition (2'-FL, 3-FL, LNnT, 3'-SL, 6'-SL) in high purity for specific purposes, enabling a stable supply that is not affected by fluctuations in the supply of natural raw materials. We have established a consistent management system that covers everything from raw material supply to manufacturing and quality control, implementing management practices that exceed international quality standards. Therefore, our products can be safely used in various applications, including infant formula ingredients, functional foods for adults, probiotic formulations, and nutritional supplements. We have a track record of exporting to international markets and provide support tailored to different applications and scales.
